A research team based at the National Eye Institute, National Institutes of Health, Bethesda, Maryland, has published long-term visual outcomes for patients participating with an… Read More »A real-world study on an AI-enabled tele-monitoring project shows significant impact on long-term outcomes.
A research team based at the Rotterdam Eye Hospital, the University of Groningen and University Eye Clinic, Maastricht, has reported that idebenone (known as Raxone),… Read More »A national cohort study in the Netherlands have reported clinical outcomes of treatment with idebenone in Leber’s hereditary optic neuropathy (LHON)
An Italian consortium of clinical researches from fourteen institutes has reported a longitudinal natural history of RPE65-assocaited retinopathies. The report, led Dr. Francesco Testa at… Read More »A longitudinal natural history of RPE65-associated retinopathies in Italy showed specific genotype-phenotype characteristics
A research study, conducted in the Department of Mechanical Engineering and School of Optometry and Vision Science at the University of Auckland, New Zealand, has… Read More »A systematic review on electronic vision prostheses suggest several improvements on methodology in order to show benefit
A research study conducted in the Medical Genetics Program of Southwestern Ontario, London Health Sciences Centre, London, Canada has shown that there are a range… Read More »Perspectives from young adults with Leber congenital amaurosis (LCA) show complex factors when considering gene therapy and trial participation
A research study assessing patient and retina specialists’ preferences on the treatment of nAMD has shown a valuable comparison on specific measures. The “relative importance”… Read More »Preferences on neovascular age-related degeneration (nAMD) treatment shows clinicians and patients’ views on options
Dutch researchers at the Radboud University Medical Centre, Nijmegen, and ProQR Therapeutics, a company, based in Leiden, the Netherlands, are enrolling up to 200 patients… Read More »Phase 2/3 anti-sense treatment (”QR-421a”) of retinitis pigmentosa (RP) aims to use exon skipping within the USH2A gene to repair the shortened usherin protein.
New longitudinal research in diabetes over a 50-year period in a US study reported that children with type-2 diabetes (T2D) had almost twice the risk… Read More »A 50-year longitudinal study of diabetes on ocular complications in youth-onset type-2 diabetes (T2D) and type 1 diabetes (T1D) suggest different risks on retinopathy
An announcement from Bausch + Lomb and Clearside Biomedical have reported that the US FDA granted approval to triamcinolone acetonide injectable suspension (“XIPERE”) for suprachoroidal… Read More »Triamcinolone acetonide for suprachoroidal injection for treatment of uveitic macular oedema approves by the FDA.
Usher syndrome (USH) is a recessive disorder characterized by retinal degeneration and sensorineural hearing impairment with Usher syndrome type 2 (USH2) is the most frequent… Read More »A large cohort of Usher syndrome type 2 (USH2) patients with mutations in the ADGRV1 gene described key characteristics of functional and structural impairment